Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Use of Pulmonary Inhalants Remains Remarkably High After Atrial Septal Defect Closure
Martina NassifOdilia I. WoudstraJoey M. KuijpersPeter J. SterkReindert P. van SteenwijkAeilko H. ZwindermanBerto J. BoumaBarbara J. MulderRobbert J. de Winter
著者情報
ジャーナル フリー HTML 早期公開
電子付録

論文ID: CJ-18-0613

この記事には本公開記事があります。
詳細
抄録

Background: Post-repair atrial septal defects (ASD) patients are frequently discharged from follow-up, but the extent of pulmonary symptoms long-term post-repair is unknown.

Methods and Results: The national CONgenital CORvitia registry was linked to the national Drug Registry to investigate all ambulatory-dispensed pulmonary inhalants for 2006–2014. ASD patients were compared with age- and sex-matched referents from the general population. A total of 1,959 adult patients (age 42±17 years; 66% female; 1,223 [62%] repaired) were included. Compared with the referents, ASD patients had more inhalant use, even at long-term post-repair follow-up (OR=1.81 [95% CI 1.62–2.03]; P<0.001).

Conclusions: ASD patients had 2-fold higher inhalant use compared with referents even at long-term post-repair follow-up, suggesting persistent pulmonary functional impairment.

著者関連情報
© 2018 THE JAPANESE CIRCULATION SOCIETY
feedback
Top